STIVARGA vs TECENTRIQ

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated October 7, 2026·How we rate

Possible drug interaction. STIVARGA and TECENTRIQ are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	STIVARGA	TECENTRIQ
Rating	New	72/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	REGORAFENIB	ATEZOLIZUMAB
Manufacturer	Bayer Hlthcare	Genentech Inc
Dosage forms	Tablet	Injectable
Drug class	—	—
Boxed warning	Boxed warning	None
Treats	Hepatocellular Carcinoma, Colorectal Neoplasms, Gastrointestinal Stromal Tumors	Urinary Bladder Neoplasms, Non-Small-Cell Lung Carcinoma, Hepatocellular Carcinoma

stivarga tecentriq

Rating

New

72/100

Pharmacy pays

—

Type

Active ingredient

REGORAFENIB

ATEZOLIZUMAB

Manufacturer

Bayer Hlthcare

Genentech Inc

Dosage forms

Tablet

Injectable

Drug class

—

Boxed warning

None

Treats

Hepatocellular Carcinoma, Colorectal Neoplasms, Gastrointestinal Stromal Tumors

Urinary Bladder Neoplasms, Non-Small-Cell Lung Carcinoma, Hepatocellular Carcinoma

Frequently asked questions

What is the difference between Stivarga and Tecentriq?

Stivarga contains Regorafenib, while Tecentriq contains Atezolizumab — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.